Keywords: msd, launches, maxalt, uk, merck, sharp, dohme

MSD Launches Maxalt In The UK

Article | 09 September 1998

Print This

Merck Sharp & Dohme's new5-HT1B/1D receptor agonist Maxalt (rizatriptan) has been launched in the UK, in both tablet ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in